Navigation Links
Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009

RIO DE JANEIRO, Brazil, May 12 /PRNewswire-FirstCall/ -- Amilpar (BOVESPA: AMIL3, Bloomberg: AMIL3 BZ and Reuters: AMIL3.SA), the largest managed care organization in Brazil, announced today its results for the first quarter of 2009.


At the end of March, total membership stood at 3.11 million, 9.7% up on the 1Q08 and 2.3% down on the 3.18 million recorded in the 4Q08.

Adjusted Operating Revenues totaled R$ 1,131 million in the 1Q09, 13.4% up year-on-year and 2.1% down on the previous quarter.

Adjusted EBITDA came to R$ 119.5 million in the 1Q09, 14.4% and 1.6 p.p. up, respectively, on the 4Q08, representing an EBITDA margin of 10.6%.

The Medical Loss Ratio for healthplan membership stood at 63.4% in the 1Q09, versus 69.0% in the 4Q08 and 65.7% in the 1Q08.

The Company posted an adjusted Net Income of R$ 78.8 million, 12.1% down on the R$ 89.6 million reported in the 1Q08.

Net Cash (cash and cash equivalents less financial debt) closed March 2009 at R$ 1,099.8 million, R$ 22 million more than at the end of 2008.

To access the Earnings Release full version visit our website at

Upcoming Events: Conference Calls

    May 13, 2009
    11:00 a.m. New York
    (12:00 noon) Brasilia
    Phone: +1 (973) 935-2966
    Code: 97090549
    Replay: +1 (706) 645-9291
    Code: 97090549
    May 13, 2009
    2:00 p.m. New York
    (3:00 p.m. Brasilia)
    Phone: +55 (11) 2188-0188
    Code: Amil
    Repaly:+55 (11) 2188-0188
    Code: Amil

About AmilPar

Amil Participacoes S.A. is the largest managed care organization in Brazil, according to the ANS, currently assisting over 3.1 million beneficiaries in the states of Sao Paulo, Rio de Janeiro, Parana and the Distrito Federal.

SOURCE Amil Participacoes S.A.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Amilpar - Revenues Increase by 26.5% and Adjusted Net Income Climbs 28.7% in 2008
2. Amilpar - Notice to Shareholders - Distribution of Interest on Capital Stock
3. Amilpar Revenues Grow 28% in the First 9 Months of 2008 and 4.5% Over Previous Quarter
4. Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007
5. Matrixx Initiatives, Inc. Reports Fiscal 2009 Revenue Increased 11% to a Record $111.6 Million and Earnings Per Share Increased 40% to $1.46
6. American Scientific Resources, Inc. Releases First Quarter Revenues
7. Clarient Reports 41% Revenue Increase for First Quarter 2009
8. Providence Service Corporation Announces Record Revenues and Earnings in the First Quarter of 2009
9. VirtualScopics Reports Record Revenues and Gross Profit in the First Quarter
10. InfuSystem Holdings Reports $9.2 Million of Revenue and 45% Increase in Adjusted EBITDA for the First Quarter of 2009
11. Reports Highest Net Revenues in Company History
Post Your Comments:
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 26, 2016 ... value-based care operating models within the health care industry ... greater financial efficiency , Deloitte offers a suite ... key business issues impacting efficient cost optimization: labor resource ... , These services facilitate better outcomes and better economics ...
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
Breaking Medicine Technology: